China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Key Highlights
- ➤1-for-100 Class A share consolidation takes effect October 26, 2026
- ➤Post-consolidation Class A shares estimated at approximately 686,775
- ➤SXTC retains its Nasdaq ticker with new CUSIP G2161P181
- ➤Class B shares remain unchanged; options and warrants adjust proportionately
China SXT Pharmaceuticals, Inc. Announces Share Consolidation PR Newswire
TAIZHOU, China, Oct. 22, 2026 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the "Company"), today announced that it will effect a share consolidation of its Class A ordinary shares, no par value per share, at a ratio of 1-for-100, effective on October 26, 2026 (the "Share Consolidation"). The Company's Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on October 26, 2026. Upon the market opening on October 26, 2026, the Company's Class A ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol "SXTC" with the new CUSIP number G2161P181.
Get started
Create a free account to read the full story.